{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-18T07:13:20.270492+00:00","published_at":"2026-10-18T07:13:20.270492+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:e1e222b19a0a0fd43e5ac0543c51b1b89d1212f1d133cf47c71e5a98e522aa30","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/eloxx-pharmaceuticals-inc","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-18T07:13:20.270492+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:published_fact:4","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:security_listing:15","stance":"supports"}],"claim_ids":["alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:legal_name:1","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:entity_status:3","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:published_fact:4","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:security_listing:15"]},{"evidence_id":"alpha:projection-evidence:document:82e3c539fc140dad42b1e0bdabfff328a33521774601c0637262e2b80e32a5b9","aliases":[],"source_type":"sec_def_14a","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","title":"SEC DEF 14A 0001140361-23-021490","identifier":null,"locator":null,"source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T05:49:03.060075+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:5","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:8","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:10","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:11","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:13","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:14","stance":"supports"}],"claim_ids":["alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:5","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:8","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:10","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:11","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:13","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:14"]},{"evidence_id":"alpha:projection-evidence:document:d53de283eb4a3d954d134cf32fec825aa57a1620dd269bb1269eb087437b2a7a","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","title":"DEF 14A ny20007761x1_def14a.htm","identifier":null,"locator":null,"source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:28:10.565677+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:6","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:7","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:9","stance":"supports"},{"claim_id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:12","stance":"supports"}],"claim_ids":["alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:6","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:7","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:9","alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:12"]}]},"claims":[{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:legal_name:1","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Eloxx Pharmaceuticals, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"Eloxx Pharmaceuticals, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:e1e222b19a0a0fd43e5ac0543c51b1b89d1212f1d133cf47c71e5a98e522aa30","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/eloxx-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-18T07:13:20.270492+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:entity_status:3","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:e1e222b19a0a0fd43e5ac0543c51b1b89d1212f1d133cf47c71e5a98e522aa30","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/eloxx-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-18T07:13:20.270492+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:published_fact:4","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:e1e222b19a0a0fd43e5ac0543c51b1b89d1212f1d133cf47c71e5a98e522aa30","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/eloxx-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-18T07:13:20.270492+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:5","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tomer-kariv-elox","object_label":"Tomer Kariv","object_source_name_forms":[],"value":"Tomer Kariv: Chairman of the Board","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tomer-kariv-elox","name":"Tomer Kariv"},"title":"Chairman of the Board","role_category":"director","committee":null,"is_board_chair":true,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:82e3c539fc140dad42b1e0bdabfff328a33521774601c0637262e2b80e32a5b9","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001140361-23-021490","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T05:49:03.060075+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:6","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alan-walts-elox","object_label":"Alan Walts","object_source_name_forms":[],"value":"Alan Walts: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alan-walts-elox","name":"Alan Walts"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-04-28","valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:d53de283eb4a3d954d134cf32fec825aa57a1620dd269bb1269eb087437b2a7a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A ny20007761x1_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:28:10.565677+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":"2023-04-28","effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:7","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:daniel-geffken-elox","object_label":"Daniel Geffken","object_source_name_forms":[],"value":"Daniel Geffken: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:daniel-geffken-elox","name":"Daniel Geffken"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-04-28","valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:d53de283eb4a3d954d134cf32fec825aa57a1620dd269bb1269eb087437b2a7a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A ny20007761x1_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:28:10.565677+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":"2023-04-28","effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:8","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lindsay-androski-eloxx-pharmaceuticals-inc","object_label":"Lindsay Androski","object_source_name_forms":[],"value":"Lindsay Androski: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lindsay-androski-eloxx-pharmaceuticals-inc","name":"Lindsay Androski"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:82e3c539fc140dad42b1e0bdabfff328a33521774601c0637262e2b80e32a5b9","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001140361-23-021490","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T05:49:03.060075+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:9","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:steve-rubin-elox","object_label":"Steve Rubin","object_source_name_forms":[],"value":"Steve Rubin: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:steve-rubin-elox","name":"Steve Rubin"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-04-28","valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:d53de283eb4a3d954d134cf32fec825aa57a1620dd269bb1269eb087437b2a7a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A ny20007761x1_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:28:10.565677+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":"2023-04-28","effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:10","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:steven-d-rubin-eloxx-pharmaceuticals-inc","object_label":"Steven D. Rubin","object_source_name_forms":[],"value":"Steven D. Rubin: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:steven-d-rubin-eloxx-pharmaceuticals-inc","name":"Steven D. Rubin"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:82e3c539fc140dad42b1e0bdabfff328a33521774601c0637262e2b80e32a5b9","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001140361-23-021490","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T05:49:03.060075+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:11","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sumit-aggarwal-elox","object_label":"Sumit Aggarwal","object_source_name_forms":[],"value":"Sumit Aggarwal: President and Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sumit-aggarwal-elox","name":"Sumit Aggarwal"},"title":"President and Chief Executive Officer and Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:82e3c539fc140dad42b1e0bdabfff328a33521774601c0637262e2b80e32a5b9","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001140361-23-021490","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T05:49:03.060075+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:12","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:vijay-modur-elox","object_label":"Vijay Modur","object_source_name_forms":[],"value":"Vijay Modur: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:vijay-modur-elox","name":"Vijay Modur"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2023-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-04-28","valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:d53de283eb4a3d954d134cf32fec825aa57a1620dd269bb1269eb087437b2a7a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A ny20007761x1_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:28:10.565677+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":"2023-04-28","effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.88,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:13","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:daniel-e-geffken","object_label":"Daniel E. Geffken","object_source_name_forms":[],"value":"Daniel E. Geffken: Interim Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:daniel-e-geffken","name":"Daniel E. Geffken"},"title":"Interim Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:82e3c539fc140dad42b1e0bdabfff328a33521774601c0637262e2b80e32a5b9","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001140361-23-021490","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T05:49:03.060075+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:leadership_role:14","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:sumit-aggarwal-elox","object_label":"Sumit Aggarwal","object_source_name_forms":[],"value":"Sumit Aggarwal: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:sumit-aggarwal-elox","name":"Sumit Aggarwal"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:document:82e3c539fc140dad42b1e0bdabfff328a33521774601c0637262e2b80e32a5b9","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001140361-23-021490","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T05:49:03.060075+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2023-04-28T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:2da99db1-7d2b-4472-b284-e3902ec86e11:security_listing:15","subject_id":"alpha:company:2da99db1-7d2b-4472-b284-e3902ec86e11","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"ELOX (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"ELOX","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:13:20.270492+00:00","sources":[{"id":"alpha:projection-evidence:e1e222b19a0a0fd43e5ac0543c51b1b89d1212f1d133cf47c71e5a98e522aa30","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/eloxx-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-18T07:13:20.270492+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:e1e222b19a0a0fd43e5ac0543c51b1b89d1212f1d133cf47c71e5a98e522aa30","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/eloxx-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-10-18T07:13:20.270492+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:82e3c539fc140dad42b1e0bdabfff328a33521774601c0637262e2b80e32a5b9","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001140361-23-021490","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-06T05:49:03.060075+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d53de283eb4a3d954d134cf32fec825aa57a1620dd269bb1269eb087437b2a7a","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"DEF 14A ny20007761x1_def14a.htm","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114036123021490/ny20007761x1_def14a.htm","source_date":"2023-04-28T00:00:00+00:00","retrieved_at":"2026-09-02T00:28:10.565677+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.817,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.814,"cross_source_agreement":0.75,"temporal_completeness":0.4},"diagnostics":{"published_claims":14,"factual_claims":14,"claims_with_linked_evidence":14,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":10,"temporal_claims_with_valid_from":4,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-18T07:13:20.270492+00:00","observed_at":"2026-10-18T07:13:20.270492+00:00","reviewed_at":"2026-10-18T07:13:20.270492+00:00","verified_at":"2026-10-18T07:13:20.270492+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":14,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/eloxx-pharmaceuticals-inc/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/eloxx-pharmaceuticals-inc?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}